Newswise Feature Channel: Men's Health

UC San Diego Health Experts Available to Discuss Prostate Cancer and Urology Awareness Month

UC San Diego Health — Wed, 04 Sep 2024 11:05:08 EST

Radiation oncology research and clinical trial results to be featured at ASTRO's Annual Meeting in Washington

American Society for Radiation Oncology (ASTRO) — Wed, 04 Sep 2024 10:15:41 EST

The American Society for Radiation Oncology (ASTRO) announced today the seven studies to be highlighted in the 2024 ASTRO Annual Meeting press program. Researchers will discuss their findings in news briefings held September 30 and October 1 at the Walter E. Washington Convention Center in Washington, D.C. and via live webcast.

National Cleveland Clinic Survey Examines Generational Divide in Men's Health

Cleveland Clinic — Wed, 04 Sep 2024 00:05:00 EST

National Cleveland Clinic Survey Examines Generational Divide in Men's Health

UCSF Prostate Cancer Program Awarded SPORE Grant by National Cancer Institute

University of California, San Francisco (UCSF) — Tue, 03 Sep 2024 07:00:13 EST

The UCSF Helen Diller Family Comprehensive Cancer Center announced today that the UCSF Prostate Cancer Program is the recipient of the National Cancer Institute's (NCI) Specialized Programs of Research Excellence (SPORE) grant for prostate cancer.

Under the radar men's health red flags may point to heart problems

University of Adelaide — Mon, 26 Aug 2024 23:05:32 EST

Adelaide researchers are calling for general practitioners to take a more proactive approach towards addressing erectile dysfunction (ED) and lower urinary tract symptoms (LUTS), in light of new findings suggesting these conditions may be linked to underlying cardiometabolic disorders. A study, recently published in the Journal of Men's Health, led by the University of Adelaide's Professor Gary Wittert and Dr Sam Tafari from SA Health with funding from The Hospital Research Foundation Group, highlighted the importance of screening for urinary symptoms in men.

Prostate Health: Understanding the Risks, Symptoms, and the Power of Screening

Rutgers Cancer Institute — Mon, 26 Aug 2024 13:05:57 EST

David M. Golombos, MD, urologic oncologist in the Urologic Oncology Program at Rutgers Cancer Institute and RWJBarnabas Health, New Jersey's only NCI-designated Comprehensive Cancer Center, shares what men need to know about prostate cancer and screening.

ChatGPT shows promise in answering patients' questions to urologists

Wolters Kluwer Health: Lippincott — Thu, 22 Aug 2024 12:00:50 EST

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice(r), an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men with Biochemically Recurrent Prostate Cancer

Johns Hopkins Medicine — Thu, 22 Aug 2024 11:00:00 EST

The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a phase II clinical trial of 51 patients conducted at the Johns Hopkins Kimmel Cancer Center and three other sites.

Mount Sinai Researchers Discover Novel Nanoparticles in Blood With Potential to Transform Cancer Diagnosis

Mount Sinai Health System — Fri, 16 Aug 2024 10:05:02 EST

Scientists at the Icahn School of Medicine at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed. The team found that these molecules undergo changes when cancer is present, suggesting their potential as biomarkers for detecting prostate cancer or as targets for therapy.

Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men

University of Maryland School of Medicine — Thu, 15 Aug 2024 16:05:21 EST

Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men

'PTNM' System provides new classification for Peyronie's disease and penile curvature

Wolters Kluwer Health: Lippincott — Fri, 09 Aug 2024 10:00:53 EST

Analysis of men seen at a specialist clinic provides new insights into the classification of Peyronie's disease (PD) subtypes, according to a report in the September issue of The Journal of Urology(r), an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Tip Sheet: BRCA cancer risks for men, a new way to classify brain tumors, funding for bile duct cancer -- and cancer care in LGBTQ+ communities

Fred Hutchinson Cancer Center — Wed, 07 Aug 2024 09:00:02 EST

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.

Study suggests an MRI may help doctors predict more aggressive prostate cancer in patients

Corewell Health — Wed, 07 Aug 2024 08:00:30 EST

New Corewell Health(tm) research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire prostate) may have more aggressive cancer in five years.

90,000 Australians go under the knife for hernia repair operations each year, with older men at highest risk

University of South Australia — Tue, 06 Aug 2024 21:05:35 EST

A new Australian study reveals who is most at risk of having hernia repair surgery, one of the most common medical conditions and surgical operations performed in hospitals worldwide.

Dr. Gopal Gupta Awarded on Newsweek America's Best Prostate Cancer Surgeons 2024 List

Loyola Medicine — Mon, 05 Aug 2024 15:05:33 EST

MAYWOOD, IL - Newsweek and Statista are proud to announce that Gopal Gupta, MD affiliated with Loyola Medicine has earned a position in the America's Best Prostate Cancer Surgeons 2024 list. This is an exclusive list of only 150 doctors in the country. Congratulations on this achievement! In an era of informed decision-making, it is increasingly important for patients to make well-founded choices about which doctor to consult for their specific condition.

Upfront mental health supports for men with prostate cancer

University of South Australia — Sun, 04 Aug 2024 16:30:53 EST

Mental health screenings must be incorporated in routine prostate cancer diagnoses say University of South Australia researchers. The call follows new research that shows men need more supports both during and immediately after a diagnosis of prostate cancer.

Understanding men's health risks: Why many avoid the doctor's office, according to a UCLA urologist

University of California, Los Angeles (UCLA), Health Sciences — Fri, 02 Aug 2024 13:05:24 EST

MSK Research Highlights, July 31, 2024

Memorial Sloan Kettering Cancer Center — Wed, 31 Jul 2024 09:05:28 EST

New research from Memorial Sloan Kettering Cancer Center (MSK) showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.

BRCA1/2: Why men should be screened for the 'breast cancer gene'

Fred Hutchinson Cancer Center — Thu, 25 Jul 2024 18:05:53 EST

According to a July 25 JAMA Oncology review article by experts at Fred Hutch Cancer Center and University of Washington, newly developed national screening guidelines offer hope for identifying the cancer risk of BRCA mutations in men through genetic testing and tailored cancer screening.

Study identifies unique treatment preference profiles in men with prostate cancer

University of California, Los Angeles (UCLA), Health Sciences — Thu, 25 Jul 2024 16:05:54 EST

The study, published in Urology Practice, reveals that while there were clear differences in treatment preferences among the profiles, these preference profiles did not significantly influence the patients' final treatment choices.